Latest Conference Articles

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

FDA Commissioner Robert Califf said that misinformation is the most common cause of death in the United States.

Healthcare practitioner finds that institutions need to acknowledge advantaged and disadvantaged groups of patients as motivation to overcome systemic barriers.

Pharmacists should get out from behind the glass from time to time and work with chronic kidney disease patients to better understand their medications and lifestyle decisions, said an analyst who spoke at ASN Kidney Week in Orlando, Florida.

Researchers outline new findings about the connection between hyperkalemia and renin-angiotensin-aldosterone system inhibitors during a session at ASN Kidney Week.

Applying the principles of precision medicine to peritoneal dialysis could improve the flexibility and personalization of care for dialysis patients.

Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.

Daniel Weiner, MD, MS, associate professor at Tufts University, discusses effective treatment approaches for diabetic kidney disease at ASN Kidney Week.

It may be worth considering the pathophysiology and vascular complications of chemotherapy, especially among patients who are already hypertensive.

An ASCP 2022 Annual Meeting session presenter provides an update of 6 new therapeutic agents and their appropriate use in an older adult population.

Pharmacy Times will be covering the American Society of Nephrology (ASN) Kidney Week, which will be gathering more than 10,000 professionals working on kidney health in Orlando, Florida.

Pharmacy Times is gearing up for Kidney Week (Nov. 3-6) by learning about the pharmacological role of kidney care from the president of the American Society of Nephrology.

Pharmacy Times will be covering the American Society of Consultant Pharmacists (ASCP) Annual Meeting, which will be gathering senior care pharmacists in San Antonio, Texas.

ASCP 2022 session presenters review the evidence that tipped the scales against the use of aspirin for primary prevention in patients aged 60 years or older.

ASCP 2022 session presenters discuss medications that can cause QTc prolongation, with a particular emphasis on a review of the literature with regards to QTc prolongation and antipsychotics.

ASCP 2022 session presenters discuss strategies and tools that can help busy pharmacists stay up to date on current medical literature, guidelines, and media.

An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.

Presenters at the AMCP Nexus conference explore outcomes data and whether these medications should be substituted for reference products more frequently.

A presentation at the AMCP Nexus conference focuses on the health care disparities and pharmacotherapy options for gender affirmation.

Presentation at the AMCP Nexus conference focuses on midterm election outlook and a plug for the Pre-approval Information Exchange Act.

Keynote speaker at the AMCP Nexus conference discusses recent FDA approvals and those scheduled over the next year.

Panelists at the AMCP Nexus conference share tips on new opportunities for students and career-changers looking to forge a new path.

Panelists at the AMCP Nexus conference discuss the burden of undertreated and untreated chronic kidney disease.

Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.

A researcher suggests that understanding specific cell function in the tumor microenvironment can help create effective and individualized immunotherapy cancer treatments.

The Academy of Managed Care Pharmacy kicks off AMCP Nexus 2022 with a wide variety of educational sessions and policy discussions.

Jeanine Singer, senior vice president of Field Sales and Operations at McKesson, discusses being appointed to the NCPA Innovation Center Board of Directors.

Yvonne Chen, PhD, discusses some of the strategies that researchers are using to improve T-cell effectiveness and overcome immunosuppression in CAR T-cell therapy.